This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $15,574.82 delivery order contract is for the supply of BioCartilage 1CC, a type of surgical biologic product. The contract is a Fixed Price with Economic Price Adjustment, with a completion date of December 23, 2024. Arthrex Inc. is a for-profit Subchapter S Corporation headquartered in Naples, Florida. This award is not designated as a set-aside contract. Arthrex Inc. also holds a larger $471,048,172.66 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, allowing VA medical centers nationwide to acquire Arthrex's innovative orthopedic technologies through task orders. This IDC, identified as SPE2DE24D0020, runs from June 11, 2024, to September 1, 2029, and includes a wide range of Arthrex's surgical implants, arthroscopic instruments, joint replacement technologies, and specialized instrument systems.
Generated 3/19/25, 9:54 AM